Advertisement

2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia

A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Published:September 23, 2015DOI:https://doi.org/10.1016/j.hrthm.2015.09.019
      Jonathan L. Halperin, MD, FACC, FAHA, Chair

      Key Words

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine (U.S.)
        Clinical Practice Guidelines We Can Trust.
        National Academies Press, Washington, DC2011
        • Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine (U.S.)
        Finding What Works in Health Care: Standards for Systematic Reviews.
        National Academies Press, Washington, DC2011
      1. ACCF/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association. 2010. Available at: http://assets.cardiosource.com/Methodology_Manual_for_ACC_AHA_Writing_Committees.pdf and http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/documents/downloadable/ucm_319826.pdf. Accessed January 23, 2015.

        • Jacobs A.K.
        • Kushner F.G.
        • Ettinger S.M.
        • et al.
        ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2013; 61: 213-265
        • Jacobs A.K.
        • Anderson J.L.
        • Halperin J.L.
        The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2014; 64: 1373-1384
        • Anderson J.L.
        • Heidenreich P.A.
        • Barnett P.G.
        • et al.
        ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2014; 63: 2304-2322
        • Halperin J.L.
        • Levine G.N.
        • Al-Khatib S.M.
        Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines.
        Journal of the American College of Cardiology. 2015; (IN PRESS)
        • Arnett D.K.
        • Goodman R.A.
        • Halperin J.L.
        • et al.
        AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services.
        J Am Coll Cardiol. 2014; 64: 1851-1856
        • Al-Khatib S.M.
        • Arshad A.
        • Balk E.M.
        • et al.
        Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: a systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
        Journal of the American College of Cardiology. 2015; (IN PRESS)
        • January C.T.
        • Wann L.S.
        • Alpert J.S.
        • et al.
        2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2014; 64: e1-e76
        • Blömstrom-Lundqvist C.
        • Scheinman M.M.
        • Aliot E.M.
        • et al.
        ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Developed in collaboration with NASPE-Heart Rhythm Society.
        J Am Coll Cardiol. 2003; 42: 1493-1531
        • Fihn S.D.
        • Blankenship J.C.
        • Alexander K.P.
        • et al.
        2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2014; 64: 1929-1949
        • Fihn S.D.
        • Gardin J.M.
        • Abrams J.
        • et al.
        2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2012; 60: e44-e164
        • Nishimura R.A.
        • Otto C.M.
        • Bonow R.O.
        • et al.
        2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2014; 63: e57-e185
        • Goff Jr., D.C.
        • Lloyd-Jones D.M.
        • Bennett G.
        • et al.
        2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2014; 63: 2935-2959
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • et al.
        2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2013; 62: e147-e239
        • Whitlock R.P.
        • Sun J.C.
        • Fremes S.E.
        • et al.
        Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
        Chest. 2012; 141: e576S-e600S
        • Camm A.J.
        • Lip G.Y.H.
        • De Caterina R.
        • et al.
        2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.
        Eur Heart J. 2012; 33: 2719-2747
        • Camm A.J.
        • et al.
        • European Heart Rhythm Association
        • European Association for Cardio-Thoracic Surgery
        Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
        Eur Heart J. 2010; 31: 2369-2429
        • Epstein A.E.
        • DiMarco J.P.
        • Ellenbogen K.A.
        • et al.
        2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2013; 61: e6-e75
        • Verma A.
        • Cairns J.A.
        • Mitchell L.B.
        • et al.
        2014 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation.
        Can J Cardiol. 2014; 30: 1114-1130
        • Cairns J.A.
        • Connolly S.
        • McMurtry S.
        • et al.
        Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
        Can J Cardiol. 2011; 27: 74-90
        • Gersh B.J.
        • Maron B.J.
        • Bonow R.O.
        • et al.
        2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2011; 58: e212-e260
        • Smith Jr., S.C.
        • Benjamin E.J.
        • Bonow R.O.
        • et al.
        AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
        J Am Coll Cardiol. 2011; 58: 2432-2446
        • Warnes C.A.
        • Williams R.G.
        • Bashore T.M.
        • et al.
        ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2008; 52: e143-e263
        • Chobanian A.V.
        • Bakris G.L.
        • Black H.R.
        • et al.
        the National High Blood Pressure Education Program Coordinating Committee: seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure.
        Hypertension. 2003; 42: 1206-1252
      2. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease.
        J Am Coll Cardiol. 2015; (IN PRESS)
        • Sheldon R.S.
        • Grubb B.P.
        • Olshansky B.
        • et al.
        2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.
        Heart Rhythm. 2015; 12: e41-e63
        • Khairy P.
        • Van Hare G.F.
        • Balaji S.
        • et al.
        PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS).
        Heart Rhythm. 2014; 11: e102-e165
        • Calkins H.
        • Kuck K.H.
        • Cappato R.
        • et al.
        2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
        J Interv Card Electrophysiol. 2012; 33: 171-257
        • Field J.M.
        • Hazinski M.F.
        • Sayre M.R.
        • et al.
        Part 1: executive summary: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.
        Circulation. 2010; 122: S640-S656
        • Orejarena L.A.
        • Vidaillet H.
        • DeStefano F.
        • et al.
        Paroxysmal supraventricular tachycardia in the general population.
        J Am Coll Cardiol. 1998; 31: 150-157
        • Calkins H.
        • Sousa J.
        • el-Atassi R.
        • et al.
        Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test.
        N Engl J Med. 1991; 324: 1612-1618
        • Kay G.N.
        • Epstein A.E.
        • Dailey S.M.
        • et al.
        Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients.
        J Cardiovasc Electrophysiol. 1993; 4: 371-389
        • Lindsay B.D.
        • Chung M.K.
        • Gamache M.C.
        • et al.
        Therapeutic end points for the treatment of atrioventricular node reentrant tachycardia by catheter-guided radiofrequency current.
        J Am Coll Cardiol. 1993; 22: 733-740
        • Jackman W.M.
        • Beckman K.J.
        • McClelland J.H.
        • et al.
        Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction.
        N Engl J Med. 1992; 327: 313-318
        • Chen S.A.
        • Chiang C.E.
        • Yang C.J.
        • et al.
        Accessory pathway and atrioventricular node reentrant tachycardia in elderly patients: clinical features, electrophysiologic characteristics and results of radiofrequency ablation.
        J Am Coll Cardiol. 1994; 23: 702-708
        • Rodriguez L.M.
        • de Chillou C.
        • Schläpfer J.
        • et al.
        Age at onset and gender of patients with different types of supraventricular tachycardias.
        Am J Cardiol. 1992; 70: 1213-1215
        • Wu D.
        • Yeh S.J.
        • Wang C.C.
        • et al.
        A simple technique for selective radiofrequency ablation of the slow pathway in atrioventricular node reentrant tachycardia.
        J Am Coll Cardiol. 1993; 21: 1612-1621
        • Clair W.K.
        • Wilkinson W.E.
        • McCarthy E.A.
        • et al.
        Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients.
        Circulation. 1993; 87: 1114-1122
        • Wu D.
        • Denes P.
        • Amat-y-Leon F.
        • et al.
        Clinical, electrocardiographic and electrophysiologic observations in patients with paroxysmal supraventricular tachycardia.
        Am J Cardiol. 1978; 41: 1045-1051
        • DiMarco J.P.
        • Miles W.
        • Akhtar M.
        • et al.
        Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
        Ann Intern Med. 1990; 113: 104-110
        • Bhandari A.K.
        • Anderson J.L.
        • Gilbert E.M.
        • et al.
        Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.
        Am Heart J. 1992; 124: 381-386
        • Sintetos A.L.
        • Roark S.F.
        • Smith M.S.
        • et al.
        Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardia.
        Arch Intern Med. 1986; 146: 2205-2209
        • Henthorn R.W.
        • Waldo A.L.
        • Anderson J.L.
        • et al.
        Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group.
        Circulation. 1991; 83: 119-125
        • Dorian P.
        • Naccarelli G.V.
        • Coumel P.
        • et al.
        A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
        Am J Cardiol. 1996; 77: 89A-95A
        • Lu C.-W.
        • Wu M.-H.
        • Chen H.-C.
        • et al.
        Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation.
        Int J Cardiol. 2014; 174: 530-534
        • Whinnett Z.I.
        • Sohaib S.M.A.
        • Davies D.W.
        Diagnosis and management of supraventricular tachycardia.
        BMJ. 2012; 345: e7769
        • Porter M.J.
        • Morton J.B.
        • Denman R.
        • et al.
        Influence of age and gender on the mechanism of supraventricular tachycardia.
        Heart Rhythm. 2004; 1: 393-396
        • Campbell R.W.
        Supraventricular tachycardia: occasional nuisance or frequent threat?.
        Eur Heart J. 1996; 17: 21-25
        • Cairns C.B.
        • Niemann J.T.
        Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia.
        Ann Emerg Med. 1991; 20: 717-721
        • Goyal R.
        • Zivin A.
        • Souza J.
        • et al.
        Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia.
        Am Heart J. 1996; 132: 765-767
        • Maryniak A.
        • Bielawska A.
        • Bieganowska K.
        • et al.
        Does atrioventricular reentry tachycardia (AVRT) or atrioventricular nodal reentry tachycardia (AVNRT) in children affect their cognitive and emotional development?.
        Pediatr Cardiol. 2013; 34: 893-897
        • González-Torrecilla E.
        • Almendral J.
        • Arenal A.
        • et al.
        Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation.
        J Am Coll Cardiol. 2009; 53: 2353-2358
        • Liu S.
        • Yuan S.
        • Hertervig E.
        • et al.
        Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome.
        J Electrocardiol. 2001; 34: 295-301
        • Anand R.G.
        • Rosenthal G.L.
        • Van Hare G.F.
        • et al.
        Is the mechanism of supraventricular tachycardia in pediatrics influenced by age, gender or ethnicity?.
        Congenit Heart Dis. 2009; 4: 464-468
        • Erdogan A.
        • Schulte B.
        • Carlsson J.
        • et al.
        [Clinical characteristics of patients with AV-nodal reentrant tachycardia (AVNRT): modification by high frequency catheter ablation. Study of 748 patients after high frequency catheter ablation].
        Med Klin (Munich). 2001; 96: 708-712
        • Lee S.H.
        • Chen S.A.
        • Wu T.J.
        • et al.
        Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia.
        Am J Cardiol. 1995; 76: 675-678
        • Walfridsson U.
        • Strömberg A.
        • Janzon M.
        • et al.
        Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardia in a Swedish population: consequences on health-related quality of life.
        Pacing Clin Electrophysiol. 2009; 32: 1299-1306
        • Cain N.
        • Irving C.
        • Webber S.
        • et al.
        Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood.
        Am J Cardiol. 2013; 112: 961-965
        • Lessmeier T.J.
        • Gamperling D.
        • Johnson-Liddon V.
        • et al.
        Unrecognized paroxysmal supraventricular tachycardia: potential for misdiagnosis as panic disorder.
        Arch Intern Med. 1997; 157: 537-543
        • Laurent G.
        • Leong-Poi H.
        • Mangat I.
        • et al.
        Influence of ventriculoatrial timing on hemodynamics and symptoms during supraventricular tachycardia.
        J Cardiovasc Electrophysiol. 2009; 20: 176-181
        • Abe H.
        • Nagatomo T.
        • Kobayashi H.
        • et al.
        Neurohumoral and hemodynamic mechanisms of diuresis during atrioventricular nodal reentrant tachycardia.
        Pacing Clin Electrophysiol. 1997; 20: 2783-2788
        • Auricchio A.
        • Klein H.
        • Trappe H.J.
        • et al.
        Lack of prognostic value of syncope in patients with Wolff-Parkinson-White syndrome.
        J Am Coll Cardiol. 1991; 17: 152-158
        • Drago F.
        • Turchetta A.
        • Calzolari A.
        • et al.
        Reciprocating supraventricular tachycardia in children: low rate at rest as a major factor related to propensity to syncope during exercise.
        Am Heart J. 1996; 132: 280-285
        • Kalusche D.
        • Ott P.
        • Arentz T.
        • et al.
        AV nodal re-entry tachycardia in elderly patients: clinical presentation and results of radiofrequency catheter ablation therapy.
        Coron Artery Dis. 1998; 9: 359-363
        • Haghjoo M.
        • Arya A.
        • Heidari A.
        • et al.
        Electrophysiologic characteristics and results of radiofrequency catheter ablation in elderly patients with atrioventricular nodal reentrant tachycardia.
        J Electrocardiol. 2007; 40: 208-213
        • Leitch J.W.
        • Klein G.J.
        • Yee R.
        • et al.
        Syncope associated with supraventricular tachycardia: an expression of tachycardia rate or vasomotor response?.
        Circulation. 1992; 85: 1064-1071
        • Razavi M.
        • Luria D.M.
        • Jahangir A.
        • et al.
        Acute blood pressure changes after the onset of atrioventricular nodal reentrant tachycardia: a time-course analysis.
        J Cardiovasc Electrophysiol. 2005; 16: 1037-1040
        • Sganzerla P.
        • Fabbiocchi F.
        • Grazi S.
        • et al.
        Electrophysiologic and haemodynamic correlates in supraventricular tachycardia.
        Eur Heart J. 1989; 10: 32-39
        • Hamdan M.H.
        • Zagrodzky J.D.
        • Page R.L.
        • et al.
        Effect of P-wave timing during supraventricular tachycardia on the hemodynamic and sympathetic neural response.
        Circulation. 2001; 103: 96-101
        • Walfridsson U.
        • Walfridsson H.
        The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation.
        Pacing Clin Electrophysiol. 2005; 28: 191-195
        • Brugada P.
        • Brugada J.
        • Mont L.
        • et al.
        A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex.
        Circulation. 1991; 83: 1649-1659
        • Vereckei A.
        • Duray G.
        • Szénási G.
        • et al.
        New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia.
        Heart Rhythm. 2008; 5: 89-98
        • Neumar R.W.
        • Otto C.W.
        • Link M.S.
        • et al.
        Part 8: adult advanced cardiovascular life support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.
        Circulation. 2010; 122: S729-S767
        • Knight B.P.
        • Zivin A.
        • Souza J.
        • et al.
        Use of adenosine in patients hospitalized in a university medical center.
        Am J Med. 1998; 105: 275-280
        • Willems S.
        • Shenasa M.
        • Borggrefe M.
        • et al.
        Atrioventricular nodal reentry tachycardia: electrophysiologic comparisons in patients with and without 2:1 infra-His block.
        Clin Cardiol. 1993; 16: 883-888
        • Pava L.F.
        • Perafán P.
        • Badiel M.
        • et al.
        R-wave peak time at DII: a new criterion for differentiating between wide complex QRS tachycardias.
        Heart Rhythm. 2010; 7: 922-926
        • Letsas K.P.
        • Weber R.
        • Siklody C.H.
        • et al.
        Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway.
        Acta Cardiol. 2010; 65: 171-176
        • Knight B.P.
        • Ebinger M.
        • Oral H.
        • et al.
        Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia.
        J Am Coll Cardiol. 2000; 36: 574-582
        • Murman D.H.
        • McDonald A.J.
        • Pelletier A.J.
        • et al.
        U.S. emergency department visits for supraventricular tachycardia, 1993-2003.
        Acad Emerg Med. 2007; 14: 578-581
        • Lim S.H.
        • Anantharaman V.
        • Teo W.S.
        • et al.
        Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage.
        Ann Emerg Med. 1998; 31: 30-35
        • Luber S.
        • Brady W.J.
        • Joyce T.
        • et al.
        Paroxysmal supraventricular tachycardia: outcome after ED care.
        Am J Emerg Med. 2001; 19: 40-42
        • Waxman M.B.
        • Wald R.W.
        • Sharma A.D.
        • et al.
        Vagal techniques for termination of paroxysmal supraventricular tachycardia.
        Am J Cardiol. 1980; 46: 655-664
        • Tavşanoglu S.
        • Ozenel E.
        Ice-water washcloth rather than facial immersion (diving reflex) for supraventricular tachycardia in adults.
        Am J Cardiol. 1985; 56: 1003
        • Wayne M.A.
        Conversion of paroxysmal atrial tachycardia by facial immersion in ice water.
        JACEP. 1976; 5: 434-435
        • Brady W.J.
        • DeBehnke D.J.
        • Wickman L.L.
        • et al.
        Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil.
        Acad Emerg Med. 1996; 3: 574-585
        • Gausche M.
        • Persse D.E.
        • Sugarman T.
        • et al.
        Adenosine for the prehospital treatment of paroxysmal supraventricular tachycardia.
        Ann Emerg Med. 1994; 24: 183-189
        • Madsen C.D.
        • Pointer J.E.
        • Lynch T.G.
        A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting.
        Ann Emerg Med. 1995; 25: 649-655
        • McCabe J.L.
        • Adhar G.C.
        • Menegazzi J.J.
        • et al.
        Intravenous adenosine in the prehospital treatment of paroxysmal supraventricular tachycardia.
        Ann Emerg Med. 1992; 21: 358-361
        • Rankin A.C.
        • Oldroyd K.G.
        • Chong E.
        • et al.
        Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias.
        Br Heart J. 1989; 62: 195-203
        • Lim S.H.
        • Anantharaman V.
        • Teo W.S.
        • et al.
        Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
        Resuscitation. 2009; 80: 523-528
      3. Adenoscan IV (adenosine injection) for rapid bolus intravenous use. U.S.Food and Drug Administration. 2015. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019937s026lbl.pdf. Accessed July 29, 2015.

        • Roth A.
        • Elkayam I.
        • Shapira I.
        • et al.
        Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states.
        Am J Cardiol. 2003; 91: 489-491
        • Stec S.
        • Kryñ̆ski T.
        • Kułakowski P.
        Efficacy of low energy rectilinear biphasic cardioversion for regular atrial tachyarrhythmias.
        Cardiol J. 2011; 18: 33-38
        • Gupta A.
        • Naik A.
        • Vora A.
        • et al.
        Comparison of efficacy of intravenous diltiazem and esmolol in terminating supraventricular tachycardia.
        J Assoc Physicians India. 1999; 47: 969-972
        • Lim S.H.
        • Anantharaman V.
        • Teo W.S.
        Slow-infusion of calcium channel blockers in the emergency management of supraventricular tachycardia.
        Resuscitation. 2002; 52: 167-174
        • Mauritson D.R.
        • Winniford M.D.
        • Walker W.S.
        • et al.
        Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial.
        Ann Intern Med. 1982; 96: 409-412
        • Winniford M.D.
        • Fulton K.L.
        • Hillis L.D.
        Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil.
        Am J Cardiol. 1984; 54: 1138-1139
        • Hindricks G.
        The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) Investigators of the Working Group on Arrhythmias of the European Society of Cardiology.
        Eur Heart J. 1993; 14: 1644-1653
        • Hindricks G.
        Incidence of complete atrioventricular block following attempted radiofrequency catheter modification of the atrioventricular node in 880 patients. Results of the Multicenter European Radiofrequency Survey (MERFS) The Working Group on Arrhythmias of the European Society of Cardiology.
        Eur Heart J. 1996; 17: 82-88
        • Spector P.
        • Reynolds M.R.
        • Calkins H.
        • et al.
        Meta-analysis of ablation of atrial flutter and supraventricular tachycardia.
        Am J Cardiol. 2009; 104: 671-677
        • Calkins H.
        • Yong P.
        • Miller J.M.
        • et al.
        Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group.
        Circulation. 1999; 99: 262-270
        • Scheinman M.M.
        • Huang S.
        The 1998 NASPE prospective catheter ablation registry.
        Pacing Clin Electrophysiol. 2000; 23: 1020-1028
        • Cheng C.H.
        • Sanders G.D.
        • Hlatky M.A.
        • et al.
        Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia.
        Ann Intern Med. 2000; 133: 864-876
        • Bohnen M.
        • Stevenson W.G.
        • Tedrow U.B.
        • et al.
        Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias.
        Heart Rhythm. 2011; 8: 1661-1666
        • Tendera M.
        • Wnuk-Wojnar A.M.
        • Kulakowski P.
        • et al.
        Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.
        Am Heart J. 2001; 142: 93-98
      4. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
        Circulation. 1995; 92: 2550-2557
        • Chimienti M.
        • Cullen M.T.
        • Casadei G.
        Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
        Eur Heart J. 1995; 16: 1943-1951
        • Anderson J.L.
        • Platt M.L.
        • Guarnieri T.
        • et al.
        Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group.
        Am J Cardiol. 1994; 74: 578-584
        • Pritchett E.L.
        • DaTorre S.D.
        • Platt M.L.
        • et al.
        Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
        J Am Coll Cardiol. 1991; 17: 297-303
        • Pritchett E.L.
        • McCarthy E.A.
        • Wilkinson W.E.
        Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
        Ann Intern Med. 1991; 114: 539-544
        • Echt D.S.
        • Liebson P.R.
        • Mitchell L.B.
        • et al.
        Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
        N Engl J Med. 1991; 324: 781-788
        • Wanless R.S.
        • Anderson K.
        • Joy M.
        • et al.
        Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias.
        Am Heart J. 1997; 133: 441-446
        • Gambhir D.S.
        • Bhargava M.
        • Nair M.
        • et al.
        Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
        Indian Heart J. 1996; 48: 133-137
        • Rathore S.S.
        • Curtis J.P.
        • Wang Y.
        • et al.
        Association of serum digoxin concentration and outcomes in patients with heart failure.
        JAMA. 2003; 289: 871-878
        • Domanovits H.
        • Laske H.
        • Stark G.
        • et al.
        Adenosine for the management of patients with tachycardias-a new protocol.
        Eur Heart J. 1994; 15: 589-593
        • Turakhia M.P.
        • Santangeli P.
        • Winkelmayer W.C.
        • et al.
        Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
        J Am Coll Cardiol. 2014; 64: 660-668
        • Steinwender C.
        • Hönig S.
        • Kypta A.
        • et al.
        Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
        Int J Cardiol. 2010; 141: 260-265
        • Tercius A.J.
        • Kluger J.
        • Coleman C.I.
        • et al.
        Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.
        Pacing Clin Electrophysiol. 2007; 30: 1331-1335
        • Pérez F.J.
        • Schubert C.M.
        • Parvez B.
        • et al.
        Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis.
        Circ Arrhythm Electrophysiol. 2009; 2: 393-401
        • de Loma-Osorio F.
        • Diaz-Infante E.
        • et al.
        Spanish Catheter Ablation Registry. 12th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2012).
        Rev Esp Cardiol (Engl Ed). 2013; 66: 983-992
        • Chen S.A.
        • Chiang C.E.
        • Yang C.J.
        • et al.
        Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation.
        Circulation. 1994; 90: 1262-1278
        • Biviano A.B.
        • Bain W.
        • Whang W.
        • et al.
        Focal left atrial tachycardias not associated with prior catheter ablation for atrial fibrillation: clinical and electrophysiological characteristics.
        Pacing Clin Electrophysiol. 2012; 35: 17-27
        • Kalman J.M.
        • Olgin J.E.
        • Karch M.R.
        • et al.
        “Cristal tachycardias”: origin of right atrial tachycardias from the crista terminalis identified by intracardiac echocardiography.
        J Am Coll Cardiol. 1998; 31: 451-459
        • Kistler P.M.
        • Sanders P.
        • Fynn S.P.
        • et al.
        Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation.
        Circulation. 2003; 108: 1968-1975
        • Kistler P.M.
        • Fynn S.P.
        • Haqqani H.
        • et al.
        Focal atrial tachycardia from the ostium of the coronary sinus: electrocardiographic and electrophysiological characterization and radiofrequency ablation.
        J Am Coll Cardiol. 2005; 45: 1488-1493
        • Natale A.
        • Breeding L.
        • Tomassoni G.
        • et al.
        Ablation of right and left ectopic atrial tachycardias using a three-dimensional nonfluoroscopic mapping system.
        Am J Cardiol. 1998; 82: 989-992
        • Goldberger J.
        • Kall J.
        • Ehlert F.
        • et al.
        Effectiveness of radiofrequency catheter ablation for treatment of atrial tachycardia.
        Am J Cardiol. 1993; 72: 787-793
        • Collins K.K.
        • Van Hare G.F.
        • Kertesz N.J.
        • et al.
        Pediatric nonpost-operative junctional ectopic tachycardia medical management and interventional therapies.
        J Am Coll Cardiol. 2009; 53: 690-697
        • Hamdan M.
        • Van Hare G.F.
        • Fisher W.
        • et al.
        Selective catheter ablation of the tachycardia focus in patients with nonreentrant junctional tachycardia.
        Am J Cardiol. 1996; 78: 1292-1297
        • Law I.H.
        • Von Bergen N.H.
        • Gingerich J.C.
        • et al.
        Transcatheter cryothermal ablation of junctional ectopic tachycardia in the normal heart.
        Heart Rhythm. 2006; 3: 903-907
        • Akar J.G.
        • Kok L.C.
        • Haines D.E.
        • et al.
        Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease.
        J Am Coll Cardiol. 2001; 38: 377-384
        • Jaïs P.
        • Shah D.C.
        • Haïssaguerre M.
        • et al.
        Mapping and ablation of left atrial flutters.
        Circulation. 2000; 101: 2928-2934
        • Coffey J.O.
        • d׳Avila A.
        • Dukkipati S.
        • et al.
        Catheter ablation of scar-related atypical atrial flutter.
        Europace. 2013; 15: 414-419
        • Triedman J.K.
        • Bergau D.M.
        • Saul J.P.
        • et al.
        Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease.
        J Am Coll Cardiol. 1997; 30: 1032-1038
        • Nakagawa H.
        • Shah N.
        • Matsudaira K.
        • et al.
        Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow “focal” ablation.
        Circulation. 2001; 103: 699-709
        • Chan D.P.
        • Van Hare G.F.
        • Mackall J.A.
        • et al.
        Importance of atrial flutter isthmus in postoperative intra-atrial reentrant tachycardia.
        Circulation. 2000; 102: 1283-1289
        • Stevenson I.H.
        • Kistler P.M.
        • Spence S.J.
        • et al.
        Scar-related right atrial macroreentrant tachycardia in patients without prior atrial surgery: electroanatomic characterization and ablation outcome.
        Heart Rhythm. 2005; 2: 594-601
        • Baker B.M.
        • Lindsay B.D.
        • Bromberg B.I.
        • et al.
        Catheter ablation of clinical intraatrial reentrant tachycardias resulting from previous atrial surgery: localizing and transecting the critical isthmus.
        J Am Coll Cardiol. 1996; 28: 411-417
        • Haines D.E.
        • Beheiry S.
        • Akar J.G.
        • et al.
        Heart Rythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety.
        Heart Rhythm. 2014; 11: e9-e51
        • Knight B.P.
        • Zivin A.
        • Souza J.
        • et al.
        A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory.
        J Am Coll Cardiol. 1999; 33: 775-781
        • Horowitz L.N.
        • Kay H.R.
        • Kutalek S.P.
        • et al.
        Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients.
        J Am Coll Cardiol. 1987; 9: 1261-1268
        • Asirvatham S.
        • Narayan O.
        Advanced catheter mapping and navigation system.
        in: Huang S.W. Wood M. Catheter Ablation of Cardiac Arrhythmias. Saunders/Elsevier, Philadelphia, PA2006: 135-161
        • Sporton S.C.
        • Earley M.J.
        • Nathan A.W.
        • et al.
        Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study.
        J Cardiovasc Electrophysiol. 2004; 15: 310-315
        • Kopelman H.A.
        • Prater S.P.
        • Tondato F.
        • et al.
        Slow pathway catheter ablation of atrioventricular nodal re-entrant tachycardia guided by electroanatomical mapping: a randomized comparison to the conventional approach.
        Europace. 2003; 5: 171-174
        • Hindricks G.
        • Willems S.
        • Kautzner J.
        • et al.
        Effect of electroanatomically guided versus conventional catheter ablation of typical atrial flutter on the fluoroscopy time and resource use: a prospective randomized multicenter study.
        J Cardiovasc Electrophysiol. 2009; 20: 734-740
        • Mah D.Y.
        • Miyake C.Y.
        • Sherwin E.D.
        • et al.
        The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia.
        Europace. 2014; 16: 277-283
        • Alvarez M.
        • Tercedor L.
        • Almansa I.
        • et al.
        Safety and feasibility of catheter ablation for atrioventricular nodal re-entrant tachycardia without fluoroscopic guidance.
        Heart Rhythm. 2009; 6: 1714-1720
        • Casella M.
        • Pelargonio G.
        • Dello R.A.
        • et al.
        “Near-zero” fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavX™ mapping system: personal experience and review of the literature.
        J Interv Card Electrophysiol. 2011; 31: 109-118
        • Razminia M.
        • Manankil M.F.
        • Eryazici P.L.S.
        • et al.
        Nonfluoroscopic catheter ablation of cardiac arrhythmias in adults: feasibility, safety, and efficacy.
        J Cardiovasc Electrophysiol. 2012; 23: 1078-1086
        • Earley M.J.
        • Showkathali R.
        • Alzetani M.
        • et al.
        Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial.
        Eur Heart J. 2006; 27: 1223-1229
        • Xu D.
        • Yang B.
        • Shan Q.
        • et al.
        Initial clinical experience of remote magnetic navigation system for catheter mapping and ablation of supraventricular tachycardias.
        J Interv Card Electrophysiol. 2009; 25: 171-174
        • Sommer P.
        • Wojdyla-Hordynska A.
        • Rolf S.
        • et al.
        Initial experience in ablation of typical atrial flutter using a novel three-dimensional catheter tracking system.
        Europace. 2013; 15: 578-581
        • Cummings J.E.
        • Pacifico A.
        • Drago J.L.
        • et al.
        Alternative energy sources for the ablation of arrhythmias.
        Pacing Clin Electrophysiol. 2005; 28: 434-443
        • Hanninen M.
        • Yeung-Lai-Wah N.
        • Massel D.
        • et al.
        Cryoablation versus RF ablation for AVNRT: a meta-analysis and systematic review.
        J Cardiovasc Electrophysiol. 2013; 24: 1354-1360
        • Friedman P.L.
        • Dubuc M.
        • Green M.S.
        • et al.
        Catheter cryoablation of supraventricular tachycardia: results of the multicenter prospective “frosty” trial.
        Heart Rhythm. 2004; 1: 129-138
        • Rodriguez-Entem F.J.
        • Expósito V.
        • Gonzalez-Enriquez S.
        • et al.
        Cryoablation versus radiofrequency ablation for the treatment of atrioventricular nodal reentrant tachycardia: results of a prospective randomized study.
        J Interv Card Electrophysiol. 2013; 36: 41-45
        • Eckhardt L.L.L.
        • Leal M.
        • Hollis Z.
        • et al.
        Cryoablation for AVNRT: importance of ablation endpoint criteria.
        J Cardiovasc Electrophysiol. 2012; 23: 729-734
        • Olshansky B.
        • Sullivan R.M.
        Inappropriate sinus tachycardia.
        J Am Coll Cardiol. 2013; 61: 793-801
        • Marcus B.
        • Gillette P.C.
        • Garson A.
        Intrinsic heart rate in children and young adults: an index of sinus node function isolated from autonomic control.
        Am Heart J. 1990; 119: 911-916
        • Jose A.D.
        • Collison D.
        The normal range and determinants of the intrinsic heart rate in man.
        Cardiovasc Res. 1970; 4: 160-167
        • Alboni P.
        • Malcarne C.
        • Pedroni P.
        • et al.
        Electrophysiology of normal sinus node with and without autonomic blockade.
        Circulation. 1982; 65: 1236-1242
        • Winum P.-F.
        • Cayla G.
        • Rubini M.
        • et al.
        A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine.
        Pacing Clin Electrophysiol. 2009; 32: 942-944
        • Romeo E.
        • Grimaldi N.
        • Sarubbi B.
        • et al.
        A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine.
        Pediatr Cardiol. 2011; 32: 842-845
        • Fox K.
        • Ford I.
        • Steg P.G.
        • et al.
        Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
        Lancet. 2008; 372: 807-816
        • Swedberg K.
        • Komajda M.
        • Böhm M.
        • et al.
        Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
        Lancet. 2010; 376: 875-885
        • Cappato R.
        • Castelvecchio S.
        • Ricci C.
        • et al.
        Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
        J Am Coll Cardiol. 2012; 60: 1323-1329
        • Benezet-Mazuecos J.
        • Rubio J.M.
        • Farré J.
        • et al.
        Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients.
        Pacing Clin Electrophysiol. 2013; 36: 830-836
        • Ptaszynski P.
        • Kaczmarek K.
        • Ruta J.
        • et al.
        Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
        Europace. 2013; 15: 116-121
        • Ptaszynski P.
        • Kaczmarek K.
        • Ruta J.
        • et al.
        Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway.
        Pacing Clin Electrophysiol. 2013; 36: 42-49
        • Ptaszynski P.
        • Kaczmarek K.
        • Ruta J.
        • et al.
        Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
        J Cardiovasc Pharmacol Ther. 2013; 18: 338-344
        • Calò L.
        • Rebecchi M.
        • Sette A.
        • et al.
        Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia.
        Heart Rhythm. 2010; 7: 1318-1323
        • Kaplinsky E.
        • Comes F.P.
        • Urondo L.S.V.
        • et al.
        Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments.
        Cardiol J. 2010; 17: 166-171
        • Rakovec P.
        Treatment of inappropriate sinus tachycardia with ivabradine.
        Wien Klin Wochenschr. 2009; 121: 715-718
        • Zellerhoff S.
        • Hinterseer M.
        • Felix Krull B.
        • et al.
        Ivabradine in patients with inappropriate sinus tachycardia.
        Naunyn Schmiedebergs Arch Pharmacol. 2010; 382: 483-486
        • Man K.C.
        • Knight B.
        • Tse H.F.
        • et al.
        Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping.
        J Am Coll Cardiol. 2000; 35: 451-457
        • Lin D.
        • Garcia F.
        • Jacobson J.
        • et al.
        Use of noncontact mapping and saline-cooled ablation catheter for sinus node modification in medically refractory inappropriate sinus tachycardia.
        Pacing Clin Electrophysiol. 2007; 30: 236-242
        • Lee R.J.
        • Kalman J.M.
        • Fitzpatrick A.P.
        • et al.
        Radiofrequency catheter modification of the sinus node for “inappropriate” sinus tachycardia.
        Circulation. 1995; 92: 2919-2928
        • Marrouche N.F.
        • Beheiry S.
        • Tomassoni G.
        • et al.
        Three-dimensional nonfluoroscopic mapping and ablation of inappropriate sinus tachycardia. Procedural strategies and long-term outcome.
        J Am Coll Cardiol. 2002; 39: 1046-1054
        • Callans D.J.
        • Ren J.F.
        • Schwartzman D.
        • et al.
        Narrowing of the superior vena cava-right atrium junction during radiofrequency catheter ablation for inappropriate sinus tachycardia: analysis with intracardiac echocardiography.
        J Am Coll Cardiol. 1999; 33: 1667-1670
        • Frankel D.S.
        • Lin D.
        • Anastasio N.
        • et al.
        Frequent additional tachyarrhythmias in patients with inappropriate sinus tachycardia undergoing sinus node modification: an important cause of symptom recurrence.
        J Cardiovasc Electrophysiol. 2012; 23: 835-839
        • Takemoto M.
        • Mukai Y.
        • Inoue S.
        • et al.
        Usefulness of non-contact mapping for radiofrequency catheter ablation of inappropriate sinus tachycardia: new procedural strategy and long-term clinical outcome.
        Intern Med. 2012; 51: 357-362
        • Koplan B.A.
        • Parkash R.
        • Couper G.
        • et al.
        Combined epicardial-endocardial approach to ablation of inappropriate sinus tachycardia.
        J Cardiovasc Electrophysiol. 2004; 15: 237-240
        • Klein I.
        • Ojamaa K.
        Thyroid hormone and the cardiovascular system.
        N Engl J Med. 2001; 344: 501-509
        • Steinbeck G.
        • Hoffmann E.
        ׳True׳ atrial tachycardia.
        Eur Heart J. 1998; 19: E48-E49
        • Wren C.
        Incessant tachycardias.
        Eur Heart J. 1998; 19: E54-E59
        • Medi C.
        • Kalman J.M.
        • Haqqani H.
        • et al.
        Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation.
        J Am Coll Cardiol. 2009; 53: 1791-1797
        • Tang C.W.
        • Scheinman M.M.
        • Van Hare G.F.
        • et al.
        Use of P wave configuration during atrial tachycardia to predict site of origin.
        J Am Coll Cardiol. 1995; 26: 1315-1324
        • Kistler P.M.
        • Roberts-Thomson K.C.
        • Haqqani H.M.
        • et al.
        P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin.
        J Am Coll Cardiol. 2006; 48: 1010-1017
        • Liu X.
        • Dong J.
        • Ho S.Y.
        • et al.
        Atrial tachycardia arising adjacent to noncoronary aortic sinus: distinctive atrial activation patterns and anatomic insights.
        J Am Coll Cardiol. 2010; 56: 796-804
        • Morton J.B.
        • Sanders P.
        • Das A.
        • et al.
        Focal atrial tachycardia arising from the tricuspid annulus: electrophysiologic and electrocardiographic characteristics.
        J Cardiovasc Electrophysiol. 2001; 12: 653-659
        • Kistler P.M.
        • Sanders P.
        • Hussin A.
        • et al.
        Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization.
        J Am Coll Cardiol. 2003; 41: 2212-2219
        • Gonzalez M.D.
        • Contreras L.J.
        • Jongbloed M.R.M.
        • et al.
        Left atrial tachycardia originating from the mitral annulus-aorta junction.
        Circulation. 2004; 110: 3187-3192
        • Ouyang F.
        • Ma J.
        • Ho S.Y.
        • et al.
        Focal atrial tachycardia originating from the non-coronary aortic sinus: electrophysiological characteristics and catheter ablation.
        J Am Coll Cardiol. 2006; 48: 122-131
        • Roberts-Thomson K.C.
        • Kistler P.M.
        • Haqqani H.M.
        • et al.
        Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation.
        J Cardiovasc Electrophysiol. 2007; 18: 367-372
        • Walters T.E.
        • Kistler P.M.
        • Kalman J.M.
        Radiofrequency ablation for atrial tachycardia and atrial flutter.
        Heart Lung Circ. 2012; 21: 386-394
        • Lee G.
        • Sanders P.
        • Kalman J.M.
        Catheter ablation of atrial arrhythmias: state of the art.
        Lancet. 2012; 380: 1509-1519
        • Markowitz S.M.
        • Nemirovksy D.
        • Stein K.M.
        • et al.
        Adenosine-insensitive focal atrial tachycardia: evidence for de novo micro-re-entry in the human atrium.
        J Am Coll Cardiol. 2007; 49: 1324-1333
        • Engelstein E.D.
        • Lippman N.
        • Stein K.M.
        • et al.
        Mechanism-specific effects of adenosine on atrial tachycardia.
        Circulation. 1994; 89: 2645-2654
        • Cossú S.F.
        • Steinberg J.S.
        Supraventricular tachyarrhythmias involving the sinus node: clinical and electrophysiologic characteristics.
        Prog Cardiovasc Dis. 1998; 41: 51-63
        • Goya M.
        • Iesaka Y.
        • Takahashi A.
        • et al.
        Radiofrequency catheter ablation for sinoatrial node reentrant tachycardia: electrophysiologic features of ablation sites.
        Jpn Circ J. 1999; 63: 177-183
        • Saoudi N.
        • Cosĺo F.
        • Waldo A.
        • et al.
        A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
        Eur Heart J. 2001; 22: 1162-1182
        • Gillette P.C.
        • Garson Jr, A.
        Electrophysiologic and pharmacologic characteristics of automatic ectopic atrial tachycardia.
        Circulation. 1977; 56: 571-575
        • Mehta A.V.
        • Sanchez G.R.
        • Sacks E.J.
        • et al.
        Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up.
        J Am Coll Cardiol. 1988; 11: 379-385
        • Eidher U.
        • Freihoff F.
        • Kaltenbrunner W.
        • et al.
        Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia.
        Pacing Clin Electrophysiol. 2006; 29: 358-362
        • Markowitz S.M.
        • Stein K.M.
        • Mittal S.
        • et al.
        Differential effects of adenosine on focal and macroreentrant atrial tachycardia.
        J Cardiovasc Electrophysiol. 1999; 10: 489-502
        • Reisinger J.
        • Gstrein C.
        • Winter T.
        • et al.
        Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks.
        Am J Emerg Med. 2010; 28: 159-165
        • Kunze K.P.
        • Kuck K.H.
        • Schlüter M.
        • et al.
        Effect of encainide and flecainide on chronic ectopic atrial tachycardia.
        J Am Coll Cardiol. 1986; 7: 1121-1126
        • Creamer J.E.
        • Nathan A.W.
        • Camm A.J.
        Successful treatment of atrial tachycardias with flecainide acetate.
        Br Heart J. 1985; 53: 164-166
        • von Bernuth G.
        • Engelhardt W.
        • Kramer H.H.
        • et al.
        Atrial automatic tachycardia in infancy and childhood.
        Eur Heart J. 1992; 13: 1410-1415
        • Lucet V.
        • Do Ngoc D.
        • Fidelle J.
        • et al.
        [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases].
        Arch Mal Coeur Vaiss. 1987; 80: 1385-1393
        • Heusch A.
        • Kramer H.H.
        • Krogmann O.N.
        • et al.
        Clinical experience with propafenone for cardiac arrhythmias in the young.
        Eur Heart J. 1994; 15: 1050-1056
        • Janousek J.
        • Paul T.
        Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
        Am J Cardiol. 1998; 81: 1121-1124
        • Colloridi V.
        • Perri C.
        • Ventriglia F.
        • et al.
        Oral sotalol in pediatric atrial ectopic tachycardia.
        Am Heart J. 1992; 123: 254-256
        • Guccione P.
        • Paul T.
        • Garson Jr, A.
        Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects.
        J Am Coll Cardiol. 1990; 15: 1118-1124
        • Coumel P.
        • Fidelle J.
        Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.
        Am Heart J. 1980; 100: 1063-1069
        • Miyazaki A.
        • Ohuchi H.
        • Kurosaki K.
        • et al.
        Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.
        Circ J. 2008; 72: 1998-2003
        • Kang K.T.
        • Etheridge S.P.
        • Kantoch M.J.
        • et al.
        Current management of focal atrial tachycardia in children: a multicenter experience.
        Circ Arrhythm Electrophysiol. 2014; 7: 664-670
        • Kothari S.A.
        • Apiyasawat S.
        • Asad N.
        • et al.
        Evidence supporting a new rate threshold for multifocal atrial tachycardia.
        Clin Cardiol. 2005; 28: 561-563
        • Yokoshiki H.
        • Mitsuyama H.
        • Watanabe M.
        • et al.
        Swallowing-induced multifocal atrial tachycardia originating from right pulmonary veins.
        J Electrocardiol. 2011; 44: 395.e1-395.e5
        • Marchlinski F.E.
        • Miller J.M.
        Atrial arrhythmias exacerbated by theophylline. Response to verapamil and evidence for triggered activity in man.
        Chest. 1985; 88: 931-934
        • Wang K.
        • Goldfarb B.L.
        • Gobel F.L.
        • et al.
        Multifocal atrial tachycardia.
        Arch Intern Med. 1977; 137: 161-164
        • Bittar G.
        • Friedman H.S.
        The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants.
        Chest. 1991; 99: 1415-1420
        • Iseri L.T.
        • Fairshter R.D.
        • Hardemann J.L.
        • et al.
        Magnesium and potassium therapy in multifocal atrial tachycardia.
        Am Heart J. 1985; 110: 789-794
        • Kastor J.A.
        Multifocal atrial tachycardia.
        N Engl J Med. 1990; 322: 1713-1717
        • Hazard P.B.
        • Burnett C.R.
        Verapamil in multifocal atrial tachycardia. Hemodynamic and respiratory changes.
        Chest. 1987; 91: 68-70
        • Mukerji V.
        • Alpert M.A.
        • Diaz-Arias M.
        • et al.
        Termination and suppression of multifocal atrial tachycardia with verapamil.
        South Med J. 1987; 80: 269-270
        • Arsura E.L.
        • Solar M.
        • Lefkin A.S.
        • et al.
        Metoprolol in the treatment of multifocal atrial tachycardia.
        Crit Care Med. 1987; 15: 591-594
        • Hazard P.B.
        • Burnett C.R.
        Treatment of multifocal atrial tachycardia with metoprolol.
        Crit Care Med. 1987; 15: 20-25
        • Kouvaras G.
        • Cokkinos D.V.
        • Halal G.
        • et al.
        The effective treatment of multifocal atrial tachycardia with amiodarone.
        Jpn Heart J. 1989; 30: 301-312
        • Levine J.H.
        • Michael J.R.
        • Guarnieri T.
        Treatment of multifocal atrial tachycardia with verapamil.
        N Engl J Med. 1985; 312: 21-25
        • Salerno D.M.
        • Anderson B.
        • Sharkey P.J.
        • et al.
        Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment.
        Ann Intern Med. 1987; 107: 623-628
        • Mehta D.
        • Wafa S.
        • Ward D.E.
        • et al.
        Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia.
        Lancet. 1988; 1: 1181-1185
        • Wen Z.C.
        • Chen S.A.
        • Tai C.T.
        • et al.
        Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia.
        Circulation. 1998; 98: 2716-2723
        • Glatter K.A.
        • Cheng J.
        • Dorostkar P.
        • et al.
        Electrophysiologic effects of adenosine in patients with supraventricular tachycardia.
        Circulation. 1999; 99: 1034-1040
        • Dougherty A.H.
        • Jackman W.M.
        • Naccarelli G.V.
        • et al.
        Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group.
        Am J Cardiol. 1992; 70: 587-592
        • Waxman H.L.
        • Myerburg R.J.
        • Appel R.
        • et al.
        Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study.
        Ann Intern Med. 1981; 94: 1-6
        • Amsterdam E.A.
        • Kulcyski J.
        • Ridgeway M.G.
        Efficacy of cardioselective beta-adrenergic blockade with intravenously administered metoprolol in the treatment of supraventricular tachyarrhythmias.
        J Clin Pharmacol. 1991; 31: 714-718
        • Das G.
        • Tschida V.
        • Gray R.
        • et al.
        Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents.
        J Clin Pharmacol. 1988; 28: 746-750
        • Alboni P.
        • Tomasi C.
        • Menozzi C.
        • et al.
        Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
        J Am Coll Cardiol. 2001; 37: 548-553
        • Yeh S.J.
        • Lin F.C.
        • Chou Y.Y.
        • et al.
        Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol.
        Circulation. 1985; 71: 104-109
        • Rinkenberger R.L.
        • Prystowsky E.N.
        • Heger J.J.
        • et al.
        Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.
        Circulation. 1980; 62: 996-1010
        • D׳Este D.
        • Zoppo F.
        • Bertaglia E.
        • et al.
        Long-term outcome of patients with atrioventricular node reentrant tachycardia.
        Int J Cardiol. 2007; 115: 350-353
        • Langberg J.J.
        • Leon A.
        • Borganelli M.
        • et al.
        A randomized, prospective comparison of anterior and posterior approaches to radiofrequency catheter ablation of atrioventricular nodal reentry tachycardia.
        Circulation. 1993; 87: 1551-1556
        • Kalbfleisch S.J.
        • Strickberger S.A.
        • Williamson B.
        • et al.
        Randomized comparison of anatomic and electrogram mapping approaches to ablation of the slow pathway of atrioventricular node reentrant tachycardia.
        J Am Coll Cardiol. 1994; 23: 716-723
        • Kay G.N.
        • Epstein A.E.
        • Dailey S.M.
        • et al.
        Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Evidence for involvement of perinodal myocardium within the reentrant circuit.
        Circulation. 1992; 85: 1675-1688
        • Bogun F.
        • Knight B.
        • Weiss R.
        • et al.
        Slow pathway ablation in patients with documented but noninducible paroxysmal supraventricular tachycardia.
        J Am Coll Cardiol. 1996; 28: 1000-1004
        • O׳Hara G.E.
        • Philippon F.
        • Champagne J.
        • et al.
        Catheter ablation for cardiac arrhythmias: a 14-year experience with 5330 consecutive patients at the Quebec Heart Institute, Laval Hospital.
        Can J Cardiol. 2007; 23: 67B-70B
        • Gambhir D.S.
        • Bhargava M.
        • Arora R.
        • et al.
        Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
        Indian Heart J. 1995; 47: 237-243
        • Musto B.
        • Cavallaro C.
        • Musto A.
        • et al.
        Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
        Am Heart J. 1992; 124: 110-115
        • Wellens H.J.
        Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram.
        Circulation. 2005; 112: 2201-2207
        • Munger T.M.
        • Packer D.L.
        • Hammill S.C.
        • et al.
        A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989.
        Circulation. 1993; 87: 866-873
        • Pappone C.
        • Vicedomini G.
        • Manguso F.
        • et al.
        Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients.
        Circulation. 2014; 130: 811-819
        • Timmermans C.
        • Smeets J.L.
        • Rodriguez L.M.
        • et al.
        Aborted sudden death in the Wolff-Parkinson-White syndrome.
        Am J Cardiol. 1995; 76: 492-494
        • Klein G.J.
        • Bashore T.M.
        • Sellers T.D.
        • et al.
        Ventricular fibrillation in the Wolff-Parkinson-White syndrome.
        N Engl J Med. 1979; 301: 1080-1085
        • Bromberg B.I.
        • Lindsay B.D.
        • Cain M.E.
        • et al.
        Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome.
        J Am Coll Cardiol. 1996; 27: 690-695
        • Santinelli V.
        • Radinovic A.
        • Manguso F.
        • et al.
        The natural history of asymptomatic ventricular pre-excitation: a long-term prospective follow-up study of 184 asymptomatic children.
        J Am Coll Cardiol. 2009; 53: 275-280
        • Smith G.D.
        • Dyson K.
        • Taylor D.
        • et al.
        Effectiveness of the Valsalva manoeuvre for reversion of supraventricular tachycardia.
        Cochrane Database Syst Rev. 2013; 3: CD009502
        • Delaney B.
        • Loy J.
        • Kelly A.-M.
        The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis.
        Eur J Emerg Med. 2011; 18: 148-152
        • Furlong R.
        • Gerhardt R.T.
        • Farber P.
        • et al.
        Intravenous adenosine as first-line prehospital management of narrow-complex tachycardias by EMS personnel without direct physician control.
        Am J Emerg Med. 1995; 13: 383-388
        • Schatz I.
        • Ordog G.J.
        • Karody R.
        • et al.
        Wolff-Parkinson-White syndrome presenting in atrial fibrillation.
        Ann Emerg Med. 1987; 16: 574-578
        • Mittal S.
        • Ayati S.
        • Stein K.M.
        • et al.
        Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks.
        Circulation. 2000; 101: 1282-1287
        • Glatter K.A.
        • Dorostkar P.C.
        • Yang Y.
        • et al.
        Electrophysiological effects of ibutilide in patients with accessory pathways.
        Circulation. 2001; 104: 1933-1939
        • Sellers Jr., T.D.
        • Campbell R.W.
        • Bashore T.M.
        • et al.
        Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.
        Circulation. 1977; 55: 15-22
        • Huycke E.C.
        • Sung R.J.
        • Dias V.C.
        • et al.
        Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study.
        J Am Coll Cardiol. 1989; 13: 538-544
        • Hamer A.
        • Peter T.
        • Platt M.
        • et al.
        Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
        Am Heart J. 1981; 101: 600-612
        • Hombach V.
        • Braun V.
        • Höpp H.W.
        • et al.
        Antiarrhythmic effects of acute beta blockade with atenolol on supraventricular tachycardias at rest and during exercise.
        Klin Wochenschr. 1981; 59: 123-133
        • Morady F.
        • DiCarlo Jr., L.A.
        • Baerman J.M.
        • et al.
        Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
        Pacing Clin Electrophysiol. 1987; 10: 492-496
        • Wellens H.J.
        • Durrer D.
        Effect of digitalis on atrioventricular conduction and circus-movement tachycardias in patients with Wolff-Parkinson-White syndrome.
        Circulation. 1973; 47: 1229-1233
        • Sellers Jr., T.D.
        • Bashore T.M.
        • Gallagher J.J.
        Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation.
        Circulation. 1977; 56: 260-267
        • Sheinman B.D.
        • Evans T.
        Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
        Br Med J (Clin Res Ed). 1982; 285: 999-1000
        • Boriani G.
        • Biffi M.
        • Frabetti L.
        • et al.
        Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.
        Am Heart J. 1996; 131: 1214-1216
        • Shiraishi H.
        • Ishibashi K.
        • Urao N.
        • et al.
        Two cases of polymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia.
        Intern Med. 2002; 41: 445-448
        • Schützenberger W.
        • Leisch F.
        • Gmeiner R.
        Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report.
        Int J Cardiol. 1987; 16: 93-95
        • Jackman W.M.
        • Wang X.Z.
        • Friday K.J.
        • et al.
        Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current.
        N Engl J Med. 1991; 324: 1605-1611
        • Calkins H.
        • Langberg J.
        • Sousa J.
        • et al.
        Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome.
        Circulation. 1992; 85: 1337-1346
        • Dagres N.
        • Clague J.R.
        • Kottkamp H.
        • et al.
        Radiofrequency catheter ablation of accessory pathways. Outcome and use of antiarrhythmic drugs during follow-up.
        Eur Heart J. 1999; 20: 1826-1832
        • Schläpfer J.
        • Fromer M.
        Late clinical outcome after successful radiofrequency catheter ablation of accessory pathways.
        Eur Heart J. 2001; 22: 605-609
        • Belhassen B.
        • Rogowski O.
        • Glick A.
        • et al.
        Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients.
        Isr Med Assoc J. 2007; 9: 265-270
        • Kugler J.D.
        • Danford D.A.
        • Deal B.J.
        • et al.
        Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society.
        N Engl J Med. 1994; 330: 1481-1487
        • Kugler J.D.
        • Danford D.A.
        • Houston K.
        • et al.
        Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry.
        Am J Cardiol. 1997; 80: 1438-1443
        • Aguinaga L.
        • Primo J.
        • Anguera I.
        • et al.
        Long-term follow-up in patients with the permanent form of junctional reciprocating tachycardia treated with radiofrequency ablation.
        Pacing Clin Electrophysiol. 1998; 21: 2073-2078
        • Kang K.T.
        • Potts J.E.
        • Radbill A.E.
        • et al.
        Permanent junctional reciprocating tachycardia in children: a multicenter experience.
        Heart Rhythm. 2014; 11: 1426-1432
        • McClelland J.H.
        • Wang X.
        • Beckman K.J.
        • et al.
        Radiofrequency catheter ablation of right atriofascicular (Mahaim) accessory pathways guided by accessory pathway activation potentials.
        Circulation. 1994; 89: 2655-2666
        • Mönnig G.
        • Wasmer K.
        • Milberg P.
        • et al.
        Predictors of long-term success after catheter ablation of atriofascicular accessory pathways.
        Heart Rhythm. 2012; 9: 704-708
        • Sakurai M.
        • Yasuda H.
        • Kato N.
        • et al.
        Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia.
        Am Heart J. 1983; 105: 619-628
        • Hopson J.R.
        • Buxton A.E.
        • Rinkenberger R.L.
        • et al.
        Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
        Am J Cardiol. 1996; 77: 72A-82A
        • Feld G.K.
        • Nademanee K.
        • Weiss J.
        • et al.
        Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
        J Am Coll Cardiol. 1984; 3: 1298-1307
        • Feld G.K.
        • Nademanee K.
        • Stevenson W.
        • et al.
        Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
        Am Heart J. 1988; 115: 102-107
        • Gemma L.W.
        • Steinberg L.A.
        • Prystowsky E.N.
        • et al.
        Development of rapid preexcited ventricular response to atrial fibrillation in a patient with intermittent preexcitation.
        J Cardiovasc Electrophysiol. 2013; 24: 347-350
        • Bauernfeind R.A.
        • Wyndham C.R.
        • Dhingra R.C.
        • et al.
        Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia.
        Circulation. 1980; 62: 1341-1349
        • Hung J.S.
        • Kou H.C.
        • Wu D.
        Digoxin, propranolol, and atrioventricular reentrant tachycardia in the Wolff-Parkinson-White syndrome.
        Ann Intern Med. 1982; 97: 175-182
        • Sharma A.D.
        • Yee R.
        • Guiraudon G.
        • et al.
        Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome.
        J Am Coll Cardiol. 1987; 10: 373-381
        • Gaita F.
        • Giustetto C.
        • Riccardi R.
        • et al.
        Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death.
        Am J Cardiol. 1989; 64: 487-490
        • Spar D.S.
        • Silver E.S.
        • Hordof A.J.
        • et al.
        Relation of the utility of exercise testing for risk assessment in pediatric patients with ventricular preexcitation to pathway location.
        Am J Cardiol. 2012; 109: 1011-1014
        • Wackel P.
        • Irving C.
        • Webber S.
        • et al.
        Risk stratification in Wolff-Parkinson-White syndrome: the correlation between noninvasive and invasive testing in pediatric patients.
        Pacing Clin Electrophysiol. 2012; 35: 1451-1457
        • Beckman K.J.
        • Gallastegui J.L.
        • Bauman J.L.
        • et al.
        The predictive value of electrophysiologic studies in untreated patients with Wolff-Parkinson-White syndrome.
        J Am Coll Cardiol. 1990; 15: 640-647
        • Pappone C.
        • Vicedomini G.
        • Manguso F.
        • et al.
        Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study.
        Circulation. 2012; 125: 661-668
        • Rinne C.
        • Klein G.J.
        • Sharma A.D.
        • et al.
        Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome.
        Am J Cardiol. 1987; 60: 576-579
        • Brembilla-Perrot B.
        • Holban I.
        • Houriez P.
        • et al.
        Influence of age on the potential risk of sudden death in asymptomatic Wolff-Parkinson-White syndrome.
        Pacing Clin Electrophysiol. 2001; 24: 1514-1518
        • Pappone C.
        • Santinelli V.
        • Manguso F.
        • et al.
        A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome.
        N Engl J Med. 2003; 349: 1803-1811
        • Pappone C.
        • Santinelli V.
        • Rosanio S.
        • et al.
        Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study.
        J Am Coll Cardiol. 2003; 41: 239-244
        • Epstein A.E.
        • Miles W.M.
        • Benditt D.G.
        • et al.
        Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology.
        Circulation. 1996; 94: 1147-1166
        • Pelliccia A.
        • Zipes D.P.
        • Maron B.J.
        Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities.
        J Am Coll Cardiol. 2008; 52: 1990-1996
        • Klein G.J.
        • Yee R.
        • Sharma A.D.
        Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern.
        N Engl J Med. 1989; 320: 1229-1233
        • Leitch J.W.
        • Klein G.J.
        • Yee R.
        • et al.
        Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern.
        Circulation. 1990; 82: 1718-1723
        • Milstein S.
        • Sharma A.D.
        • Klein G.J.
        Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern.
        Am J Cardiol. 1986; 57: 1097-1100
        • Satoh M.
        • Aizawa Y.
        • Funazaki T.
        • et al.
        Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-White pattern.
        Pacing Clin Electrophysiol. 1989; 12: 413-420
        • Havránek S.
        • Simek J.
        • St׳ovĺǒek P.
        • et al.
        Distribution of mean cycle length in cavo-tricuspid isthmus dependent atrial flutter.
        Physiol Res. 2012; 61: 43-51
        • Waldo A.L.
        • Feld G.K.
        Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications.
        J Am Coll Cardiol. 2008; 51: 779-786
        • Ellis K.
        • Wazni O.
        • Marrouche N.
        • et al.
        Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence.
        J Cardiovasc Electrophysiol. 2007; 18: 799-802
        • Hsieh M.-H.
        • Tai C.-T.
        • Chiang C.-E.
        • et al.
        Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients.
        J Interv Card Electrophysiol. 2002; 7: 225-231
        • Tai C.T.
        • Chen S.A.
        • Chiang C.E.
        • et al.
        Long-term outcome of radiofrequency catheter ablation for typical atrial flutter: risk prediction of recurrent arrhythmias.
        J Cardiovasc Electrophysiol. 1998; 9: 115-121
        • Paydak H.
        • Kall J.G.
        • Burke M.C.
        • et al.
        Atrial fibrillation after radiofrequency ablation of type I atrial flutter: time to onset, determinants, and clinical course.
        Circulation. 1998; 98: 315-322
        • Chinitz J.S.
        • Gerstenfeld E.P.
        • Marchlinski F.E.
        • et al.
        Atrial fibrillation is common after ablation of isolated atrial flutter during long-term follow-up.
        Heart Rhythm. 2007; 4: 1029-1033
        • Reithmann C.
        • Hoffmann E.
        • Spitzlberger G.
        • et al.
        Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation.
        Eur Heart J. 2000; 21: 565-572
        • Bertaglia E.
        • Bonso A.
        • Zoppo F.
        • et al.
        Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
        Pacing Clin Electrophysiol. 2004; 27: 1507-1512
        • Satomi K.
        • Chun K.R.J.
        • Tilz R.
        • et al.
        Catheter ablation of multiple unstable macroreentrant tachycardia within the right atrium free wall in patients without previous cardiac surgery.
        Circ Arrhythm Electrophysiol. 2010; 3: 24-31
        • Seiler J.
        • Schmid D.K.
        • Irtel T.A.
        • et al.
        Dual-loop circuits in postoperative atrial macro re-entrant tachycardias.
        Heart. 2007; 93: 325-330
        • Roberts-Thomson K.C.
        • Kistler P.M.
        • Kalman J.M.
        Focal atrial tachycardia I: clinical features, diagnosis, mechanisms, and anatomic location.
        Pacing Clin Electrophysiol. 2006; 29: 643-652
        • Barbato G.
        • Carinci V.
        • Tomasi C.
        • et al.
        Is electrocardiography a reliable tool for identifying patients with isthmus-dependent atrial flutter?.
        Europace. 2009; 11: 1071-1076
        • Akar J.G.
        • Al-Chekakie M.O.
        • Hai A.
        • et al.
        Surface electrocardiographic patterns and electrophysiologic characteristics of atrial flutter following modified radiofrequency MAZE procedures.
        J Cardiovasc Electrophysiol. 2007; 18: 349-355
        • Chugh A.
        • Latchamsetty R.
        • Oral H.
        • et al.
        Characteristics of cavotricuspid isthmus-dependent atrial flutter after left atrial ablation of atrial fibrillation.
        Circulation. 2006; 113: 609-615
        • Shah D.
        ECG manifestations of left atrial flutter.
        Curr Opin Cardiol. 2009; 24: 35-41
        • Nakagawa H.
        • Jackman W.M.
        Use of a 3-dimensional electroanatomical mapping system for catheter ablation of macroreentrant right atrial tachycardia following atriotomy.
        J Electrocardiol. 1999; 32: 16-21
        • Delacretaz E.
        • Ganz L.I.
        • Soejima K.
        • et al.
        Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping.
        J Am Coll Cardiol. 2001; 37: 1665-1676
        • Magnin-Poull I.
        • De Chillou C.
        • Miljoen H.
        • et al.
        Mechanisms of right atrial tachycardia occurring late after surgical closure of atrial septal defects.
        J Cardiovasc Electrophysiol. 2005; 16: 681-687
        • Kanagasundram A.N.
        • Baduashvili A.
        • Liu C.F.
        • et al.
        A novel criterion for conduction block after catheter ablation of right atrial tachycardia after mitral valve surgery.
        Circ Arrhythm Electrophysiol. 2013; 6: 39-47
        • Teh A.W.
        • Medi C.
        • Lee G.
        • et al.
        Long-term outcome following ablation of atrial flutter occurring late after atrial septal defect repair.
        Pacing Clin Electrophysiol. 2011; 34: 431-435
        • McElderry H.T.
        • McGiffin D.C.
        • Plumb V.J.
        • et al.
        Proarrhythmic aspects of atrial fibrillation surgery: mechanisms of postoperative macroreentrant tachycardias.
        Circulation. 2008; 117: 155-162
        • Wazni O.M.
        • Saliba W.
        • Fahmy T.
        • et al.
        Atrial arrhythmias after surgical maze: findings during catheter ablation.
        J Am Coll Cardiol. 2006; 48: 1405-1409
        • Gerstenfeld E.P.
        • Callans D.J.
        • Dixit S.
        • et al.
        Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation.
        Circulation. 2004; 110: 1351-1357
        • Chugh A.
        • Oral H.
        • Lemola K.
        • et al.
        Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation.
        Heart Rhythm. 2005; 2: 464-471
        • Veenhuyzen G.D.
        • Knecht S.
        • O׳Neill M.D.
        • et al.
        Atrial tachycardias encountered during and after catheter ablation for atrial fibrillation: part I: classification, incidence, management.
        Pacing Clin Electrophysiol. 2009; 32: 393-398
        • Karch M.R.
        • Zrenner B.
        • Deisenhofer I.
        • et al.
        Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies.
        Circulation. 2005; 111: 2875-2880